Low shear stress induces ERK nuclear localization and YAP activation to control the proliferation of breast cancer cells.
Active Transport, Cell Nucleus
Adaptor Proteins, Signal Transducing
/ metabolism
Breast Neoplasms
/ metabolism
Cell Line, Tumor
Cell Nucleus
/ metabolism
Cell Proliferation
Cytoplasm
/ metabolism
Female
Gene Expression Regulation, Neoplastic
Humans
Mitogen-Activated Protein Kinase 1
/ metabolism
Mitogen-Activated Protein Kinase 3
/ metabolism
Phosphoproteins
/ metabolism
Phosphorylation
Shear Strength
Stress, Mechanical
Transcription Factors
YAP-Signaling Proteins
ERK
Low shear stress
Mechanotransduction
Nucleus translocation
YAP
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
05 03 2019
05 03 2019
Historique:
received:
03
01
2019
accepted:
12
01
2019
pubmed:
28
1
2019
medline:
13
11
2019
entrez:
28
1
2019
Statut:
ppublish
Résumé
Micro-environmental regulation of cancer cell malignancy is one of the most basic cancer life phenomena. However, the study of cellular response to microenvironment has been long focused on signal processes mediated by various chemical factors and their receptors, the study of mechanical forces, another key environmental factor, has been less studied. In recent years, more and more attention has been paid to the physiological and pathological significance of mechanical microenvironment. However, it is still not clear how cells perceive environmental changes and the signal pathways that regulate cell physiological activities. In this study, we identified that low shear stress (LSS) significantly promoted breast cancer cell proliferation. The proliferation was closely associated with mitogen-activated protein kinase (MAPK) extracellular signal-regulated kinase (ERK) and Yes-associated protein (YAP). Inhibition of ERK or YAP both abolished the LSS-induced proliferation activity of cancer cells. LSS induced ERK phosphorylation and YAP activations, which suggested the involvement of ERK and YAP under LSS treatment. Under LSS, ERK inhibitor U0126 decreased both active YAP and ERK expressions, while YAP inhibitor verteporfin failed to decrease ERK phosphorylation. Further study confirmed that ERK translocated to nucleus which showed an active state of ERK in LSS-treated group. LSS with verteporfin group showed no differences with LSS-treated group which confirmed ERK and YAP an upstream-downstream cascade. The above results demonstrated that LSS can promote breast cancer cell proliferation through ERK-YAP activation. These results not only highlight a new means of understanding mechanical transmission to cytoplasm mechanisms but also serve as a new basis for developing drug delivery systems for breast cancer treatment.
Identifiants
pubmed: 30685085
pii: S0006-291X(19)30079-8
doi: 10.1016/j.bbrc.2019.01.065
pii:
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Phosphoproteins
0
Transcription Factors
0
YAP-Signaling Proteins
0
YAP1 protein, human
0
MAPK1 protein, human
EC 2.7.11.24
MAPK3 protein, human
EC 2.7.11.24
Mitogen-Activated Protein Kinase 1
EC 2.7.11.24
Mitogen-Activated Protein Kinase 3
EC 2.7.11.24
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
219-223Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.